Abiopharma

🔍 Miranda Tiago (Executive)

Company: Atlas Lithium Corp (ATLX)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 30,000 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Acquired 105,543 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 105,543.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On June 15, 2026, the Reporting Person entered into an Amended and Restated Employment Agreement with the Issuer, pursuant to which 30,000 previously reported restricted stock units ("RSUs") granted under the Issuer's 2023 Stock Incentive Plan (the "Plan") were cancelled and the Reporting Person was granted 105,543 new RSUs under the Plan. The new RSUs vest in four equal annual installments beginning on July 23, 2026.